Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Glioma NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01248949
What this trial is testing

Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Recurrent Ovarian Tumors
MedImmune LLC 162
Not applicableLooking for participantsNCT07612917
What this trial is testing

Brain Connectivity Changes in Glioma Patients During Treatment

Who this might be right for
Glioma (Any Grade) in the BrainGliomas, MalignantfMRI Research+1 more
Johannes Kepler University of Linz 20
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Large-scale testing (Phase 3)Study completedNCT02892708
What this trial is testing

Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over

Who this might be right for
Malignant Glioma
Assistance Publique - Hôpitaux de Paris 107
Testing effectiveness (Phase 2)Study completedNCT00939991
What this trial is testing

Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas

Who this might be right for
Brain TumorGlioblastoma
Katy Peters 48
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00147160
What this trial is testing

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

Who this might be right for
Glioma
Gustave Roussy, Cancer Campus, Grand Paris 87
Early research (Phase 1)WithdrawnNCT04521946
What this trial is testing

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

Who this might be right for
Anaplastic EpendymomaAtypical Teratoid/Rhabdoid TumorCentral Nervous System Germ Cell Tumor+12 more
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT01316809
What this trial is testing

AZD8055 for Adults With Recurrent Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00539344
What this trial is testing

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Who this might be right for
Recurrent or Progressive Malignant Glioma
Angiochem Inc 63
Early research (Phase 1)WithdrawnNCT04741984
What this trial is testing

Monocyte Antigen Carrier Cells for Newly Diagnosed GBM

Who this might be right for
GlioblastomaGlioma, Malignant
Michael Gunn
Early research (Phase 1)Active Not RecruitingNCT03749187
What this trial is testing

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Who this might be right for
GlioblastomaIDH1 Gene MutationIDH2 Gene Mutation+7 more
University of California, San Francisco 78
Testing effectiveness (Phase 2)UnknownNCT00283543
What this trial is testing

Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma

Who this might be right for
Newly Diagnosed Supratentorial Malignant Glioma
Kentuckiana Cancer Institute 40
Very early researchActive Not RecruitingNCT03893487
What this trial is testing

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Who this might be right for
Diffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
Sabine Mueller, MD, PhD 30
Early research (Phase 1)UnknownNCT02331693
What this trial is testing

CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR

Who this might be right for
Advanced Glioma
RenJi Hospital 10
Early research (Phase 1)Ended earlyNCT06270082
What this trial is testing

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Cancer+7 more
Ikena Oncology 75
Testing effectiveness (Phase 2)Looking for participantsNCT06640582
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+4 more
Essen Biotech 85
Early research (Phase 1)Study completedNCT00005637
What this trial is testing

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Next Page